SCHEMBL6792935

SCHEMBL6792935

Cn1ncn(-c2ccc(Br)cn2)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.36
MAPT P10636 2/20 0.36
DPP4 P27487 1/20 0.36
GBA1 P04062 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
AKR1C3 P42330 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
GAA P10253 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20644657 0.81 PIK3CD (0.30) MAPTRAB9A
SCHEMBL16197227 0.76 NPC1 (0.44) HSD17B10ALDH1A1KDM4EMAPTNPC1
SCHEMBL6796919 0.73 ELANE (0.40) ALDH1A1KDM4EMAPTDPP4AKR1C3
SCHEMBL31729279 0.71 CHRNB2 (0.38) HSD17B10ALDH1A1MAPTNPC1RAB9A
SCHEMBL27267442 0.71 ALDH1A1 (0.51) HSD17B10ALDH1A1KDM4EMAPTDPP4
SCHEMBL6798000 0.70 GPR119 (0.44) HSD17B10ALDH1A1KDM4EMAPTDPP4
SCHEMBL8133065 0.70 HCAR1 (0.50) HSD17B10MAPTTSHR
SCHEMBL30930948 0.69 KDM4E (0.36) ALDH1A1KDM4EMAPTGAA
SCHEMBL20639751 0.69 MAPT (0.46) ALDH1A1KDM4EMAPTAKR1C3NPC1
SCHEMBL16196802 0.69 RXFP1 (0.42) MAPTRXFP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689779-B2 PYRIDINE OR PYRIMIDINE SUBSTITUTED; ANTIBACTERIAL ACTIVITY; LOW TOXICITY DONG A PHARM. CO., LTD. (KR) 2004-02-10 US disclosed
US-20030166620-A1 Novel oxazolidinone derivatives and a process for the preparation thereof DONG A PHARM. CO., LTD. (KR) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166620-A1 Novel oxazolidinone derivatives and a process for the preparation thereof OXA1L, ODC1, PDCD4 HSD17B10 853/4885ALDH1A1 939/4885KDM4E 1158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.